Selected article for: "anti antibody and CTL response"

Author: Vijayan, Veena; Mohapatra, Adityanarayan; Uthaman, Saji; Park, In-Kyu
Title: Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials
  • Document date: 2019_10_14
  • ID: 1d3xthbh_64
    Snippet: Fcγ receptor targeting and anti-cancer therapy [146] OVA antigen CTL response and cancer immune therapy [147] Endolysin Degradation of bacterial protein and anti-bacterial therapy [102] Env-2-3-SF2, IL-7 Strong antibody response and anti-HIV therapy [107] MPER and MPLA, STING, cdGMP.....
    Document: Fcγ receptor targeting and anti-cancer therapy [146] OVA antigen CTL response and cancer immune therapy [147] Endolysin Degradation of bacterial protein and anti-bacterial therapy [102] Env-2-3-SF2, IL-7 Strong antibody response and anti-HIV therapy [107] MPER and MPLA, STING, cdGMP

    Search related documents:
    Co phrase search for related documents
    • anti bacterial therapy and immune therapy: 1, 2, 3
    • anti cancer therapy and cancer immune therapy: 1, 2, 3, 4, 5, 6
    • anti cancer therapy and immune therapy: 1, 2, 3, 4, 5, 6, 7, 8
    • anti hiv therapy and immune therapy: 1, 2, 3, 4
    • antibody response and cancer immune therapy: 1
    • antibody response and fcγ receptor: 1, 2, 3
    • antibody response and immune therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • antibody response and strong antibody response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cancer immune therapy and immune therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25